AVROBIO, Inc.
COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
Last updated:
Abstract:
Described herein are methods for treating a subject having or at risk of developing a neurocognitive disorder, such as frontotemporal lobar degeneration or neuronal ceroid lipofuscinosis, by administering cells that contain a transgene encoding a progranulin (PGRN) or a granulin (GRN) or cells that express the PGRN or the GRN to the subject. Also disclosed are compositions comprising cells containing the transgene encoding the PGRN or the GRN.
Status:
Application
Type:
Utility
Filling date:
31 Jan 2020
Issue date:
14 Apr 2022